Abstract
Curcumin shows several pharmacological activities with low toxicity, but its low water solubility limits its usage. To overcome these drawback, methoxy poly(ethylene glycol)-b-poly ( $$\delta$$ -valerolactone) was synthesized through ring-opening polymerization with mPEG and $$\delta$$ -valerolactone as raw materials and hydrochloride ethyl ether as catalyst. The nanoparticles were developed by thin-film hydration and used as the delivery system for curcumin. The pharmacokinetics, in vitro release and safety of curcumin-loaded nanoparticles were evaluated. The results showed that nanoparticles had high drug-loading capacity (11.70 %) and entrapment efficiency (92.66 %). The water solubility of curcumin was increased to 1.851 mg/mL, which was approximately 1.73 × 105 times higher than that of free curcumin. The plasma AUC0–∞ and V z of curcumin-loaded nanoparticles were 3.60- and 4.56-fold higher than that of curcumin control solution, respectively. The CLz of curcumin-loaded nanoparticles was decreased by 3.60-fold. The MRT0–∞ changed from 0.284 to 4.657 h. Hemolysis test results revealed that the mPEG–PVL was safe for intravenous injection. These results clearly showed that the curcumin-loaded nanoparticles were suitable to be a delivery vehicle for curcumin.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
